372320 — Curocell Balance Sheet
0.000.00%
- KR₩445bn
- KR₩456bn
Annual balance sheet for Curocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | — | — | IFRS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 41,143 | 40,979 | 7,126 | 39,917 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 22.1 | 616 | 2,183 | 746 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 41,446 | 64,161 | 41,397 | 42,787 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 9,880 | 17,809 | 46,104 | 61,242 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 51,473 | 82,163 | 87,988 | 104,969 |
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 45,922 | 84,837 | 106,648 | 3,270 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Funded Status | ||||
Total Liabilities | 49,050 | 94,399 | 135,586 | 45,870 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
ESOP Debt Guarantee | ||||
Other Equity | ||||
Total Equity | 2,424 | -12,236 | -47,598 | 59,100 |
Total Liabilities & Shareholders' Equity | 51,473 | 82,163 | 87,988 | 104,969 |
Total Common Shares Outstanding |